Consultation by: Care Quality Commission

The Care Quality Commission (CQC) consulted on proposed changes to assessing and rating health and social care providers. Healthwatch Birmingham & Solihull responded to ensure patient and public views shaped clearer, more transparent regulatory frameworks. We supported sector-specific assessment frameworks and clearer rating characteristics, stressing accessible information and meaningful engagement. However, we raised concerns about the lack of examples in the consultation, noting that draft rating formats or multimedia explanations would have helped people understand the impact of the proposed changes.

Consultation by: Department of Health and Social Care

The Department of Health and Social Care consulted on proposals to allow pharmacists to substitute medicines when the prescribed item is unavailable. Healthwatch Birmingham & Solihull supported increased flexibility where it helps prevent delays to treatment. We emphasised the need for clear, accessible information for patients when substitutions are made, consistent monitoring of how decisions are applied, and notifying prescribers so they can respond to any follow up concerns. We recommended that dedicated training should be implemented ahead of the suggested changes. We also highlighted risks for patients who may struggle to understand changes without clear explanations and noted that strict word limits in the consultation restricted respondents’ ability to fully outline their views.

Consultation by: Department of Health and Social Care

The Department of Health and Social Care consulted on proposals to widen the range of medicines that Optometrists and Contact Lens Opticians can supply directly to patients. Healthwatch Birmingham & Solihull responded in support of measures that could improve access to timely care in community settings. We highlighted the need for clear referral pathways for patients who cannot be treated in the community, accessible information about the changes, and straightforward feedback and complaints routes. We also raised concerns about the potential for increased inequalities and the cost of medicines acting as a barrier for people on low incomes.